← 返回

基因操作与细胞免疫疗法联合在癌症治疗中的应用

英文原题:The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer.

查看英文原题

The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer.

PubMed 2022/04/01(内容时间) Iran J Biotechnol Q4 · IF 1.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本综述描述了基因工程与细胞免疫治疗的结合带来了新型抗肿瘤抑制分子,阻止肿瘤组织免疫耐受并显著扩展了癌症治疗的有效性。通常,细胞免疫治疗和基因工程被视为两个独立的过程,而在本综述中,我们认为它们是结合的。在此,我们回顾了这两种新方法,它们在技术进步和临床经验方面都是结合。

研究思路结论见上方概要

免疫系统与肿瘤直接相关,从肿瘤形成到肿瘤发展和转移。因此,科学家对保护性免疫机制的兴趣增加,并在癌症治疗中展现出有前景的策略。证据获取:基因工程和细胞免疫治疗是两种不同的先进分子机制,用于修饰免疫反应和基因组。基因操作是一种生物工程技术,允许载体将新的遗传信息转移到靶细胞中。细胞免疫治疗是一种卓越的策略,将机体免疫系统与抗击癌症联系起来。结果与

展开英文摘要原文

CONTEXT: The immune system is directly linked to the tumors, from tumor formation to the tumor's development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer treatment. EVIDENCE ACQUISITION: Genetic engineering and cellular immunotherapy are two different advanced molecular mechanisms to modify the immune responses and genome. Gene manipulation is the bioengineering technology that allows vectors to transfer new genetic information into the target cells. Cellular immunotherapy is an excellent strategy that connects the body's immune system to fight cancer. RESULTS & CONCLUSIONS: This review described that combination of genetic engineering and cellular immunotherapy has brought the novel antitumor repressive molecules stopping the tumor tissue immune tolerance and significantly expanding cancer therapy's effectiveness. Usually, cell immunotherapy and genetic engineering are considered two independent processes, and, in this review, we believe them in combinations. Here, we review these two novel approaches, and they are both combinations in terms of technological advances and clinical experience.

论文信息

作者
Khatami F、Aghamir ZS、Jahanshahi F、Feiz-Abadi SA、Birang F、Khoshchehreh M、Namazi Shabestari A、Aghamir SMK
单位
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.Iran
文献类型
综述
期刊
Iranian journal of biotechnology2022 Apr
原文标识
PubMed 36337063 · DOI 10.30498/ijb.2022.294933.3094